Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (91-100 of 222) with videos related to

Pageof 23
Sort By:
Anticancer Research|July 15, 2009
New markers and multivariate models for prostate cancer detectionCarsten Stephan, Harry Rittenhouse, Henning Cammann, et al.
Clinical Chemistry and Laboratory Medicine|September 26, 2009
Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?Carsten Stephan, Thomas Köpke, Axel Semjonow, et al.
European Urology|February 2, 2010
Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumoursFlorian Jentzmik, Carsten Stephan, Kurt Miller, et al.
Oncotarget|November 8, 2017
The prostate health index PHI predicts oncological outcome and biochemical recurrence after radical prostatectomy - analysis in 437 patientsAndreas Maxeiner, Ergin Kilic, Julia Matalon, et al.
Biological Chemistry|April 17, 2012
The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancerNicole M A White, Youssef M Youssef, Annika Fendler, et al.
Clinical Biochemistry|February 20, 2007
Free PSA forms in prostatic tissue and sera of prostate cancer patients: analysis by 2-DE and western blotting of immunopurified samplesGlòria Tabarés, Klaus Jung, Janett Reiche, et al.
Clinical Chemistry|October 9, 2004
Analysis of subforms of free prostate-specific antigen in serum by two-dimensional gel electrophoresis: potential to improve diagnosis of prostate cancerKlaus Jung, Janett Reiche, Axel Boehme, et al.
Urology|May 30, 2009
Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural networkCarsten Stephan, Henning Cammann, Serdar Deger, et al.
Clinical Chemistry|May 27, 2003
Determination of non-alpha1-antichymotrypsin-complexed prostate-specific antigen as an indirect measurement of free prostate-specific antigen: analytical performance and diagnostic accuracySebastian Wesseling, Carsten Stephan, Axel Semjonow, et al.
International Journal of Molecular Sciences|December 6, 2018
UBC<sup>®</sup> <i>Rapid</i> Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-StudyThorsten H Ecke, Sarah Weiß, Carsten Stephan, et al.
Pageof 23

Showing results (91-100 of 222) with videos related to

Sort By:
Pageof 23
Anticancer Research|July 15, 2009
New markers and multivariate models for prostate cancer detectionCarsten Stephan, Harry Rittenhouse, Henning Cammann, et al.
Clinical Chemistry and Laboratory Medicine|September 26, 2009
Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?Carsten Stephan, Thomas Köpke, Axel Semjonow, et al.
European Urology|February 2, 2010
Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumoursFlorian Jentzmik, Carsten Stephan, Kurt Miller, et al.
Oncotarget|November 8, 2017
The prostate health index PHI predicts oncological outcome and biochemical recurrence after radical prostatectomy - analysis in 437 patientsAndreas Maxeiner, Ergin Kilic, Julia Matalon, et al.
Biological Chemistry|April 17, 2012
The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancerNicole M A White, Youssef M Youssef, Annika Fendler, et al.
Clinical Biochemistry|February 20, 2007
Free PSA forms in prostatic tissue and sera of prostate cancer patients: analysis by 2-DE and western blotting of immunopurified samplesGlòria Tabarés, Klaus Jung, Janett Reiche, et al.
Clinical Chemistry|October 9, 2004
Analysis of subforms of free prostate-specific antigen in serum by two-dimensional gel electrophoresis: potential to improve diagnosis of prostate cancerKlaus Jung, Janett Reiche, Axel Boehme, et al.
Urology|May 30, 2009
Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural networkCarsten Stephan, Henning Cammann, Serdar Deger, et al.
Clinical Chemistry|May 27, 2003
Determination of non-alpha1-antichymotrypsin-complexed prostate-specific antigen as an indirect measurement of free prostate-specific antigen: analytical performance and diagnostic accuracySebastian Wesseling, Carsten Stephan, Axel Semjonow, et al.
International Journal of Molecular Sciences|December 6, 2018
UBC<sup>®</sup> <i>Rapid</i> Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-StudyThorsten H Ecke, Sarah Weiß, Carsten Stephan, et al.
Pageof 23